Antimicrobial Resistance
Problem Pathogens and Clinical Countermeasures
Herausgeber: Owens, Robert C.; Lautenbach, Ebbing
Antimicrobial Resistance
Problem Pathogens and Clinical Countermeasures
Herausgeber: Owens, Robert C.; Lautenbach, Ebbing
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This publication provides a state-of-the-art overview of key issues related to antimicrobial resistance, including a focus on key pathogens causing common healthcare-associated and community-acquired infections. The epidemiology and therapeutic considerations of these antimicrobial resistant organisms are discussed, as well as the clinical and heal
Andere Kunden interessierten sich auch für
Antibiotic Residues, Antimicrobial Resistance and Intervention Strategies of Foodborne Pathogens73,99 €
Molecular Detection, Characterization, Antimicrobial Resistance and Genomic Epidemiology of Pathogenic Bacteria68,99 €
Antimicrobial Activity of Natural Products and Plants Extracts77,99 €
Functional Polymers as Innovative Tools in the Delivery of Antimicrobial Agents68,99 €
Monitoring and Surveillance of Veterinary Antimicrobial Use and Antibiotic Resistance in Animals84,99 €
Azhar Ul Haque SarioAntimicrobial Resistance and Control24,99 €
Antimicrobial Prescribing, Population Use and Resistance, Impact in Global Health70,99 €-
-
-
This publication provides a state-of-the-art overview of key issues related to antimicrobial resistance, including a focus on key pathogens causing common healthcare-associated and community-acquired infections. The epidemiology and therapeutic considerations of these antimicrobial resistant organisms are discussed, as well as the clinical and heal
Produktdetails
- Produktdetails
- Verlag: CRC Press
- Seitenzahl: 516
- Erscheinungstermin: 22. Dezember 2007
- Englisch
- Abmessung: 235mm x 157mm x 32mm
- Gewicht: 890g
- ISBN-13: 9780824729417
- ISBN-10: 0824729412
- Artikelnr.: 22951538
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: CRC Press
- Seitenzahl: 516
- Erscheinungstermin: 22. Dezember 2007
- Englisch
- Abmessung: 235mm x 157mm x 32mm
- Gewicht: 890g
- ISBN-13: 9780824729417
- ISBN-10: 0824729412
- Artikelnr.: 22951538
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Robert C. Owens, Ebbing Lautenbach
RESISTANCE CONCERNS FOR THE PRACTICING CLINICIAN: GENERAL CONSIDERATIONS.
Measuring the Costs of Antimicrobial Resistance in Hospitals. Surveillance
of Resistant Organisms: Whats to know? Role of New Drug Development in
Combatting Resistance. Understanding Studies of Resistant Organisms: Focus
on Methodologies. CONTEMPORARY ANTIMICROBIAL RESISTANCE ISSUES. Gram
positive. Staphylococcus aureus: Resistance Update and Treatment Options.
Enterococci: Resistance Update and Treatment Options. Streptococcus
pneumoniae: Resistance Update and Treatment Options. Gram negative.
Enterobacteriaceae: Resistance Update and Treatment Options. Acinetobacter
species: Resistance Update and Treatment Options. P. aeruginosa: Resistance
Update and Treatment Options. Problematic Beta-lactamases (AMP C, ESBLs):
An Update. Others. Clostridium difficile and Antimicrobial Resistance: An
emerging epidemic. Emerging Resistance Among Fungal Pathogens: Trends and
Treatment Considerations. Interventional Strategies to Combat Resistance.
Empirical Therapy: Importance of Getting it Right up Front/Deescalation.
Antimicrobial Cycling Strategies: Whats the Evidence? Antimicrobial
Stewardship Programs. Computer Assisted Programs to Optimize Antimicrobial
Use. Pharmacodynamic Optimization to Prevent Resistance. Short Course
Antimicrobial Therapy. Use of Guidelines to Optimize Antimicrobial Use.
Infection Control Strategies: Current Controversies and Solutions.
Combination Antimicrobial Therapy: What is the Evidence? Strategies to
Optimize the Outpatient Use of Antimicrobials
Measuring the Costs of Antimicrobial Resistance in Hospitals. Surveillance
of Resistant Organisms: Whats to know? Role of New Drug Development in
Combatting Resistance. Understanding Studies of Resistant Organisms: Focus
on Methodologies. CONTEMPORARY ANTIMICROBIAL RESISTANCE ISSUES. Gram
positive. Staphylococcus aureus: Resistance Update and Treatment Options.
Enterococci: Resistance Update and Treatment Options. Streptococcus
pneumoniae: Resistance Update and Treatment Options. Gram negative.
Enterobacteriaceae: Resistance Update and Treatment Options. Acinetobacter
species: Resistance Update and Treatment Options. P. aeruginosa: Resistance
Update and Treatment Options. Problematic Beta-lactamases (AMP C, ESBLs):
An Update. Others. Clostridium difficile and Antimicrobial Resistance: An
emerging epidemic. Emerging Resistance Among Fungal Pathogens: Trends and
Treatment Considerations. Interventional Strategies to Combat Resistance.
Empirical Therapy: Importance of Getting it Right up Front/Deescalation.
Antimicrobial Cycling Strategies: Whats the Evidence? Antimicrobial
Stewardship Programs. Computer Assisted Programs to Optimize Antimicrobial
Use. Pharmacodynamic Optimization to Prevent Resistance. Short Course
Antimicrobial Therapy. Use of Guidelines to Optimize Antimicrobial Use.
Infection Control Strategies: Current Controversies and Solutions.
Combination Antimicrobial Therapy: What is the Evidence? Strategies to
Optimize the Outpatient Use of Antimicrobials
RESISTANCE CONCERNS FOR THE PRACTICING CLINICIAN: GENERAL CONSIDERATIONS.
Measuring the Costs of Antimicrobial Resistance in Hospitals. Surveillance
of Resistant Organisms: Whats to know? Role of New Drug Development in
Combatting Resistance. Understanding Studies of Resistant Organisms: Focus
on Methodologies. CONTEMPORARY ANTIMICROBIAL RESISTANCE ISSUES. Gram
positive. Staphylococcus aureus: Resistance Update and Treatment Options.
Enterococci: Resistance Update and Treatment Options. Streptococcus
pneumoniae: Resistance Update and Treatment Options. Gram negative.
Enterobacteriaceae: Resistance Update and Treatment Options. Acinetobacter
species: Resistance Update and Treatment Options. P. aeruginosa: Resistance
Update and Treatment Options. Problematic Beta-lactamases (AMP C, ESBLs):
An Update. Others. Clostridium difficile and Antimicrobial Resistance: An
emerging epidemic. Emerging Resistance Among Fungal Pathogens: Trends and
Treatment Considerations. Interventional Strategies to Combat Resistance.
Empirical Therapy: Importance of Getting it Right up Front/Deescalation.
Antimicrobial Cycling Strategies: Whats the Evidence? Antimicrobial
Stewardship Programs. Computer Assisted Programs to Optimize Antimicrobial
Use. Pharmacodynamic Optimization to Prevent Resistance. Short Course
Antimicrobial Therapy. Use of Guidelines to Optimize Antimicrobial Use.
Infection Control Strategies: Current Controversies and Solutions.
Combination Antimicrobial Therapy: What is the Evidence? Strategies to
Optimize the Outpatient Use of Antimicrobials
Measuring the Costs of Antimicrobial Resistance in Hospitals. Surveillance
of Resistant Organisms: Whats to know? Role of New Drug Development in
Combatting Resistance. Understanding Studies of Resistant Organisms: Focus
on Methodologies. CONTEMPORARY ANTIMICROBIAL RESISTANCE ISSUES. Gram
positive. Staphylococcus aureus: Resistance Update and Treatment Options.
Enterococci: Resistance Update and Treatment Options. Streptococcus
pneumoniae: Resistance Update and Treatment Options. Gram negative.
Enterobacteriaceae: Resistance Update and Treatment Options. Acinetobacter
species: Resistance Update and Treatment Options. P. aeruginosa: Resistance
Update and Treatment Options. Problematic Beta-lactamases (AMP C, ESBLs):
An Update. Others. Clostridium difficile and Antimicrobial Resistance: An
emerging epidemic. Emerging Resistance Among Fungal Pathogens: Trends and
Treatment Considerations. Interventional Strategies to Combat Resistance.
Empirical Therapy: Importance of Getting it Right up Front/Deescalation.
Antimicrobial Cycling Strategies: Whats the Evidence? Antimicrobial
Stewardship Programs. Computer Assisted Programs to Optimize Antimicrobial
Use. Pharmacodynamic Optimization to Prevent Resistance. Short Course
Antimicrobial Therapy. Use of Guidelines to Optimize Antimicrobial Use.
Infection Control Strategies: Current Controversies and Solutions.
Combination Antimicrobial Therapy: What is the Evidence? Strategies to
Optimize the Outpatient Use of Antimicrobials







